Insights
Little Green Pharma to commence trading on ASX 20 February
Little Green Pharma raised the maximum subscription amount of $10 million in an oversubscribed IPO.
Feb 2020
Good Manufacturing Practices licence granted
Company news
27 Oct 2020
Little Green Pharma was recently granted a Therapeutic Goods Administration (TGA) Good Manufacturing Practices (GMP) licence for its recently commissioned manufacturing facility in Western Australia. This license means:
- LGP will now be able to produce medicinal cannabis flower products
- LGP has the benefit of enhanced manufacturing capacity in addition to our existing pharmaceutical manufacturer
- strong supply reliability for patients
The GMP licencing of the Company’s manufacturing facility is the culmination of a two-year regulatory strategy.
Little Green Pharma now holds over 20 State and Federal operating authorisations, allowing it to operate a fully in-house and vertically-integrated cannabis cultivation, production, manufacturing, and wholesaling supply chain, capable of supplying various LGP branded medicinal cannabis products into Australian and international markets.
The manufacturing facility was constructed with funding support from the West Australian Government and represents a regional manufacturing success story for South West Western Australia.
You might also be interested in
Company news
First Australian-grown cannabis medicines
Little Green Pharma (LGP), is the first Australian company to locally-grow and produce medicinal cannabis products for sale to Australian patients. The first products are now ready to be delivered to patients.
Aug 2018
Insights
Little Green Pharma (ASX:LGP) receives manufacturing permit
We have been granted a new manufacturing permit from the Office of Drug Control. Read more...
May 2020